COLPOFIX® FAQ

Colpofix® treatment is recommended for all women infected by Human Papillomavirus, whether they have developed cervical lesions or not. In those women who have not developed cervical lesions, Colpofix® is effective as a preventive treatment. In women with cervical lesions, Colpofix® is an effective treatment which promotes lesion regression and re-epithelialisation.

Colpofix® is an innovative vaginal spray gel indicated for the prevention and treatment of cervical lesions caused by Human Papillomavirus. It acts through the control of physiological conditions on the cervico-vaginal transformation zone.

Thanks to the properties of its active ingredients, polycarbophil and carboxymethyl beta-glucan, Colpofix® forms a protective barrier over the cervico-vaginal mucosa which protects the affected area from the deleterious action of external microbial agents. Additionally, Colpofix® promotes the re-epithelialisation and regression of cervical lesions, as well as the restoration and maintenance of a healthy vaginal microbiota, ensuring a significant improvement in vaginal health thanks to the prebiotic effect of carboxymethyl beta-glucan.

Yes, it is. Colpofix® is totally compatible with natural rubber latex condoms.

It is advisable to perform one application (5 sprays) per day, in the evening before going to bed.

1 bottle corresponds to 10 days of use. It should be renewed according to the recommendations of your doctor.

Colpofix® is exclusively formulated for cervico-vaginal application, and not for external use. It is therefore not intended for treating genital warts.

Each vaginal applicator must only be used once and discarded immediately afterwards.